News & Articles
Selected Filters:
More than 90% effective: Pfizer and BioNTech announce phase 3 COVID-19 vaccine results
Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected
New accessible microscope design opens up understanding of bio-molecules
The microscope aims to give microbiologists a greater insight into how single bio-molecules behave
Abbott introduces next-generation 3D cardiac mapping platform in Europe and Australia
The EnSite X EP System is a new cardiac mapping system designed from electrophysiologist input to optimize cardiac ablation procedures
Improved LC-MS analysis of oligonucleotides with next-generation chromatography
Join us Wednesday, November 18, to discover the impact metal interactions have on oligo analysis
PerkinElmer to acquire cell engineering company Horizon Discovery
Addition of CRISPR and RNAi offerings to complement PerkinElmer's life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine
Researchers to develop anti-COVID-19 coating for PPE
This project aims to produce an antiviral and antifouling coating which can be used on PPE to protect staff working in healthcare settings
Diagnosis of bacterial and fungal pathogens using culture-independent molecular testing
Join us Monday, November 16, to explore the advantages and applications of direct molecular testing
Bio-Rad launches three StarBright dyes for flow cytometry
The StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 dyes aim to offer maximal brightness for improved resolution
Latest advances in protein biology
From ultrafiltration and extraction to glycosylation and imaging, discover the latest technologies, top tips, and best practices for protein biology research
Olympus announces acquisition of FH ORTHO, an international orthopedics company in France
To expand Minimally Invasive Surgery field by reinforcing its orthopedics business
PerkinElmer receives CE Mark for multi-analyte respiratory panel including COVID-19
Company’s latest test enables differential diagnosis between COVID-19, flu and RSV infection
EKF launches PrimeStore MTM pathogenic sample collection and transportation kit
New sample collection kit enables convenient and safe collection, transportation and handling of pathogenic samples including COVID-19 and influenza
Study shows high blood pressure and its drug treatment unlikely to increase entry of COVID-19 virus into cells
Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic
Nominate your favorite new lab product for a Scientists’ Choice Award: Nominations open today
Which new products made the most difference to your lab work this year?
PerkinElmer introduces no-wash immunoassay to help drive neuroscience disease research forward
New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s
SelectScience: Why mental health is top of our agenda
Study using Mission Bio’s Tapestri platform reveals clonal diversity underlying AML and therapy resistance
The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance
Merck’s new VirusExpress platform speeds development of cell and gene therapies
Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies
Pacific Biosciences and Invitae to develop whole genome sequencing-based assays for pediatric epilepsy diagnostics
The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy
FDA approves Gilead's antiviral remdesivir drug for treatment of COVID-19
Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days